> A university doesn't want to spend $200 million to run the drug trials for a new drug. And I suspect university researchers don't want to spend their time managing such trials either.
Yes, so outsource the trials to academic hospitals or specialized companies. Pay them properly and don't grant them a patent based on just doing the trials (they are a lot of work but they are not an inventive step).
Yes, so outsource the trials to academic hospitals or specialized companies. Pay them properly and don't grant them a patent based on just doing the trials (they are a lot of work but they are not an inventive step).